CAV1 - GLUT3 signaling is important for cellular energy and can be targeted by Atorvastatin in Non-Small Cell Lung Cancer

Background: The development of molecular targeted therapies, such as EGFR-TKIs, has positively impacted the management of EGFR mutated NSCLC. However, patients with innate and acquired resistance to EGFR-TKIs still face limited effective therapeutic options. Statins are the most frequently prescribe...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Theranostics
Glavni autori: Ali, Azhar, Levantini, Elena, Fhu, Chee Wai, Teo, Jun Ting, Clohessy, John G., Goggi, Julian L., Wu, Chan-shuo, Chen, Leilei, Chin, Tan Min, Tenen, Daniel G
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2019
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6735519/
https://ncbi.nlm.nih.gov/pubmed/31534543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.35805
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items